Search all trials

Find therapies in clinical trials near you – page 39

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Breast cancer

Not recruiting

Registered drug

Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Myelofibrosis

Not recruiting

Registered drugNo placebo

Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:ALKYLATING AGENTS

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on the Safety and Effects of IMG-007 for Adults with Moderate to Severe Atopic Dermatitis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Img-007

Contact Research Centre

Chronic cutaneous lupus erythematosus+2

Not recruiting

Investigational

Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Litifilimab

Contact Research Centre

Neoplasm

Not recruiting

Registered drug

Study of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Plasma cell myeloma+1

Not recruiting

Registered drugNo placebo

Study Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Hepatitis B

Not recruiting

Investigational

Study on the Safety and Effectiveness of GSKVX000000008866 and GSKVX000000009151 in Adults with Chronic Hepatitis B on Nucleotide Analogue Therapy

Investigational

Germany

Participants:18–64 years
Substances:Gskvx000000008866

Contact Research Centre

Breast cancer metastatic

Not recruiting

Registered drug

Study comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Giredestrant

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drug

Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cetrelimab

Contact Research Centre

Follicle centre lymphoma follicular grade I II - III refractory

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Epcoritamab

Contact Research Centre

Metastatic renal cell carcinoma

Not recruiting

Registered drugNo placebo

Study Comparing Nivolumab and Cabozantinib with Sunitinib for Patients with Untreated Advanced Kidney Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cabozantinib

Contact Research Centre

Find therapies in clinical trials near you – page 39

605 trials match your criteria

Breast cancer

Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

Myelofibrosis

Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment

Dermatitis atopic

Study on the Safety and Effects of IMG-007 for Adults with Moderate to Severe Atopic Dermatitis

Chronic cutaneous lupus erythematosus+2

Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Neoplasm

Study of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors

Plasma cell myeloma+1

Study Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma

Hepatitis B

Study on the Safety and Effectiveness of GSKVX000000008866 and GSKVX000000009151 in Adults with Chronic Hepatitis B on Nucleotide Analogue Therapy

Breast cancer metastatic

Study comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer

Hepatic cirrhosis

Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

Bladder transitional cell carcinoma

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Follicle centre lymphoma follicular grade I II - III refractory

Study on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

Metastatic renal cell carcinoma

Study Comparing Nivolumab and Cabozantinib with Sunitinib for Patients with Untreated Advanced Kidney Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.